Document ID: chunk:federal_register_of_legislation:F2022L00906:reg:9:p2
Version: federal_register_of_legislation:F2022L00906
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6810–9776

taking a long-acting opioid at an average daily morphine equivalent dose of at least 75 milligrams for at least the 2 months before the clinical onset of central sleep apnoea;
Note: central sleep apnoea and long-acting opioid are defined in the Schedule 1 – Dictionary.
(10)      having heart failure at the time of the clinical worsening of sleep apnoea;
(11)      having a central nervous system lesion or disorder from the specified list of central nervous system lesions or disorders at the time of the clinical worsening of sleep apnoea;
            Note: specified list of central nervous system lesions or disorders is defined in the Schedule 1 – Dictionary.
(12)      having autonomic neuropathy at the time of the clinical worsening of sleep apnoea;
Note: autonomic neuropathy is defined in the Schedule 1 – Dictionary.
(13)      having chronic renal failure at the time of the clinical worsening of sleep apnoea;
Note: chronic renal failure is defined in the Schedule 1 – Dictionary.
(14)      having a neuromuscular disease affecting the diaphragm, other respiratory muscles or upper airway muscles at the time of the clinical worsening of sleep apnoea;
            Note 1: Examples of a neuromuscular disease affecting the diaphragm, other respiratory muscles or upper airway muscles include myasthenia gravis, postpolio syndrome and motor neurone disease.
Note 2: upper airway is defined in the Schedule 1 – Dictionary.
(15)      having acromegaly at the time of the clinical worsening of sleep apnoea;
Note: acromegaly is defined in the Schedule 1 – Dictionary.
(16)      consuming an average of at least 30 grams of alcohol per day for at least the 6 months before the clinical worsening of sleep apnoea;
            Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(17)      taking an antipsychotic drug for at least the 2 months before the clinical worsening of sleep apnoea;
(18)      for obstructive sleep apnoea only:
(a)          having hypothyroidism, including Hashimoto thyroiditis that has resulted in hypothyroidism, at the time of the clinical worsening of obstructive sleep apnoea;
(b)          having chronic obstruction or chronic narrowing of the upper airway at the time of the clinical worsening of obstructive sleep apnoea;
               Note: upper airway is defined in the Schedule 1 – Dictionary.
(c)          being obese at the time of the clinical worsening of obstructive sleep apnoea;
Note: being obese is defined in the Schedule 1 – Dictionary.
(d)          being a supine position when sleeping for at least the 6 months before the clinical worsening of obstructive sleep apnoea; or
(e)          taking protease inhibitors as antiretroviral drugs for human immunodeficiency virus infection before the clinical worsening of obstructive sleep apnoea;
Note: obstructive sleep apnoea is defined in the Schedule 1 - Dictionary.
(19)      for central